de Clavijo I V, Weart C W
Department of Community Pharmacy Practice and Administration, Medical University of South Carolina, Charleston.
Ann Pharmacother. 1994 May;28(5):633-42. doi: 10.1177/106002809402800514.
To provide an overview of childhood immunizations with emphasis in new recommendations, as well as recent vaccine developments and special populations.
English language literature identified via a MEDLINE search. Additional references were obtained from cited references.
Original articles, reviews, and official publications were used to obtain the most accurate data on safety and efficacy of available pediatric vaccines, as well as current recommendations for their use.
Immunizations have been an area of vigorous research for several years. New vaccines have been developed by improving older products to maximize immunogenicity and minimize adverse effects. Some of these novel vaccines, like the Haemophilus influenzae type b conjugate vaccines (HibCV), have already contributed significantly to the prevention of diseases in childhood. New recommendations have been issued to help speed this process. Adverse effects of routine immunizations are generally mild and transient.
The development of new effective and safe vaccines for children is an important step in the global eradication of contagious diseases. A new generation of combination vaccines has started with the combination of the diphtheria-tetanus-pertussis vaccine and HibCV. Some other combined products are yet to come that would eventually make immunization schedules more cost-effective and improve compliance rates. Our colleagues in the community and in the ambulatory care setting must actively participate in the implementation of vaccination programs and provide education to parents regarding all aspects of the immunization process.
概述儿童免疫接种情况,重点介绍新建议、近期疫苗研发进展以及特殊人群。
通过医学文献数据库检索确定的英文文献。其他参考文献来自引用文献。
使用原始文章、综述和官方出版物获取关于现有儿科疫苗安全性和有效性的最准确数据,以及当前的使用建议。
免疫接种多年来一直是活跃的研究领域。通过改进旧产品开发了新疫苗,以最大限度提高免疫原性并最小化不良反应。其中一些新型疫苗,如b型流感嗜血杆菌结合疫苗(HibCV),已对预防儿童疾病做出了重大贡献。已发布新建议以加速这一进程。常规免疫接种的不良反应通常轻微且短暂。
开发新的有效且安全的儿童疫苗是全球根除传染病的重要一步。新一代联合疫苗已从白喉-破伤风-百日咳疫苗与HibCV的联合开始。其他一些联合产品也即将问世,最终将使免疫接种计划更具成本效益并提高依从率。我们社区和门诊护理机构的同事必须积极参与疫苗接种计划的实施,并就免疫接种过程的各个方面对家长进行教育。